It can happen even after a mild case and at any age, although rates have declined since the pandemic’s early years. Studies show vaccination can lower the risk. It also is not clear what causes long ...

Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public ...

The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...

In this study, the authors estimated that Paxlovid reduced the risk of hospitalization by 39% (95% confidence interval [CI], ...

The Department of Health Services has awarded $590 million to Moderna to speed up the development of flu vaccines, including ...

Daily Podcasts & Video News – Keep up-to-date with the Thaiger while at work or on-the-go by listening in to the daily ...

Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market in record time and quickly generating blockbuster revenue from it.

Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government ...

Shares of Moderna Inc. fell sharply on Monday after the biotech firm projected a steep decline in 2025 revenues, falling below Wall Street expectations. The company, known for its COVID-19 vaccine ...

Federal funding for COVID-19 vaccines will stop this year and the provinces and territories will be responsible for buying them, as well as determining the timing of the vaccinations, the Public ...